Ignite Creation Date:
2024-05-06 @ 10:34 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03291860
Status:
UNKNOWN
Last Update Posted:
2017-09-25
First Post:
2017-09-18
Brief Title:
Antimullerian Hormone as an Indicator for Ovarian Response
Sponsor:
Ain Shams Maternity Hospital
Organization:
Ain Shams Maternity Hospital
Study Overview
Official Title:
Antimullerian Hormone as an Indicator fo Ovarian Response in Women Receiving Long GnRH Agonist Protocol in Intracytoplasmic Sperm Injection Cycles
Status:
UNKNOWN
Status Verified Date:
2017-09
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Anti Mullerian hormone AMH is gaining place as ovarian marker chiefly in infertility assistance
Investigators explored its correlation with oocytes retrieval after long GnRH agonist protocol for stimulation in younger and older infertile population Methods This prospective analysis compiled data of 66 females receiving ICSI treatment from April 2016 to October 2017 Serum FSH LH Estadiol AMH and antral follicle count were assessed Outcomes were measured as good 5 to 19 oocytes and bad responders
Investigators explored its correlation with oocytes retrieval after long GnRH agonist protocol for stimulation in younger and older infertile population Methods This prospective analysis compiled data of 66 females receiving ICSI treatment from April 2016 to October 2017 Serum FSH LH Estadiol AMH and antral follicle count were assessed Outcomes were measured as good 5 to 19 oocytes and bad responders
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None